Genomics England, with the consent of participants and the support of the public, is creating a lasting legacy for patients, the NHS and the UK economy through the sequencing of 100,000 genomes: the 100,000 Genomes Project.
Genomics England was set up by the Department of Health to deliver the 100,000 Genomes Project. Initially the focus will be on rare disease, cancer and infectious disease.
Genomics England has announced today a partnership with the NIHR National Biosample Centre, opened in January by the Minister for Life Sciences George Freeman. The £24 million state-of-the-art facility will store the samples of rare disease and cancer patients taking part in the 100,000 Genomes Project.
The Milton Keynes-based Centre, which is the largest biosample facility in the UK, was opened to help increase national capacity and capability to develop research. The NIHR National Biosample Centre will store and process biological samples such as blood, tumour tissue and saliva, keeping samples at temperatures as low as -80°C. It will also undertake a range of precision analyses, including extraction of DNA.
What is genomics?
Our Head of Engagement, Vivienne Parry, explains more about genomics in this film courtesy of our partners at Health Education England.